期刊文献+

抗凝血性高分子生物材料的表面改性方法研究进展 被引量:2

A Study of Surface Modification of Polymeric Biomaterials for Antithromgenicity
下载PDF
导出
摘要 改善材料的血液相容性是高分子生物材料研究领域中重要的性能指标,而对材料进行表面改性又是这一环节中的关键。综述了抗凝血高分子材料的3种设计方法:生物化学表面改性、物理化学表面改性及表面形态改性。生物化学表面改性包括材料表面的接枝改性、引入生物活性物质、微相分离、内皮细胞化。物理化学表面改性包括等离子体表面改性、表面自组装分子层。材料的表面形态改性包括表面粗糙度的控制等。并总结了以上方法的研究进程及存在的问题。 Improving the blood-compatibility is the most important property with regard to polymeric biomaterial,and the surface modification is the key. Three design methods of surface modification on polymeric biomaterial are summarized,which are biochemistry surface modification,physical chemistry surface modification and surface conformation modification. First of all,the method of biochemistry surface modification is discussed,including surface graft modification,introducing bioactivity substances,micro-phase separation and endothelial cells seeding. Secondly,physical chemistry surface modification includes plasma surface modification,self-assembled monolayers. Thirdly,the surface conformation modification comprises control of the surface roughness. Additionally,the main procedures and questions of these methods are reviewed.
作者 姚婉清
出处 《嘉应学院学报》 2010年第5期53-57,共5页 Journal of Jiaying University
关键词 高分子生物材料 抗凝血性 表面改性 血液相容性 polymeric biomaterials antithrombogenicity surface modification blood-compatibility
  • 相关文献

参考文献16

二级参考文献301

共引文献176

同被引文献32

  • 1王鹏,罗建斌,杜民慧,何成生,樊翠蓉,钟银屏.以PEG和PTMG为混合软段的聚氨酯的合成、表征及血液相容性研究[J].生物医学工程学杂志,2005,22(4):734-738. 被引量:6
  • 2Choi WS,Bae JW,Joung YK,et al.Fabrication of endothelial cell-specific polyurethane surface co-immobilized with GRGDS and YIGSR peptides.Macromol Res.2009;17(7):458-463.
  • 3Macocinschi D,Filip D,Vlad S,et al.Segmented biopolyurethanes for medical applications.J Mater Sci Mater Med.2009;20(8):1659-1668.
  • 4Vlad S,Filip D,Macocinschi D,et al.New polyetherurethanes based on cellulose derivative for biomedical applications.Optoelectr Adv Mat Rapid Commun.2010;4(3):407-414.
  • 5Satish CS,Kumar C,Narasimhamurthy S,et al.Biocompatibility issues of implanted polymeric materials.Indian J Pharmac Educ Res.2007;41(3):195-204.
  • 6Thevenot P,Hu WJ,Tang LP.Surface chemistry influences implant biocompatibility.Curr Top Med Chem.2008;8(4):270-280.
  • 7Chen H,Yuan L,Song W,et al.Biocompatible polymer materials:Role of protein-surface interactions.Prog Polym Sci.2008;33(11):1059-1087.
  • 8Blit PH,Shen YH,Ernsting MJ,et al.Bioactivation of porous polyurethane scaffolds using fluorinated RGD surface modifiers.J Biomed Mater Res A.2010;94A(4):1226-1235.
  • 9Goodman SB,Barrena EG,Takagi M,et al.Biocompatibility of total joint replacements:A review.J Biomed Mater Res A.2009; 90A(2):603-618.
  • 10Hridya VK,Jayabalan M.Studies on in vitro biostability and blood compatibility of polyurethane potting compound based on aromatic polymeric MDI for extracorporeal devices.J Mater Sci Mater Med.2009;20 Suppl 1:S195-202.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部